| |||||||
|
Executive Summary BioSeeker Group has identified over 300 industry related R&D projects utilizing a tumor antigen strategy for anticancer immune stimulation. These projects have been grouped into four main categories - "pure" antigens or biological drugs, cell therapies, anti-idiotypic antibodies and gene therapies. BioSeeker is also providing in-depth knowledge of industry efforts in tumor antigen discovery, delivery, and presentation; as well as different techniques for improving the immune response. Decision-making requires a vast amount of structured information. Although paramount to establishing a representative description of a particular field, identifying and structuring information is a tedious task. When generating an information structure, it is essential to make it as complete as possible in order to analyse and draw correct conclusions from the field. For your convenience, BioSeeker Group has identified and structured more than 300 industry related cancer vaccine R&D projects, compiled in the first edition of this database. This collection of data describes the R&D activities in this field as near completely as possible. Compiling the information in a database file for convenient transfer of data to your preferred information system will save hundreds of working hours for you. Depending on the aim of your analysis, it will enable you to produce simple as well as advanced information analysis on the spot. Use the database to produce key tables and automated graphs in no more than a few minutes! Release date: Oct 7, 2003 Publisher: BioSeeker 2003 To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/BioSeeker_2003.html#a463
|
|
| ||||||||